Effect of Clofibrate Administration on Plasma Post-heparin Lipolytic Activity in Man

Clofibrate treatment for 15-20 days (1500 mg/day) of diabetic patients with endogenous hypertriglyceridemia produced a significant increase in the plasma post-heparin lipolytic activity. Single administration of the drug (500 mg) did not affect the lipolytic activity though it resulted in an elevati...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Tohoku Journal of Experimental Medicine 1974, Vol.113(4), pp.343-349
Hauptverfasser:	MARUHAMA, YOSHISUKE, YANBE, AKIRA, ABE, RYUZO, OHNEDA, AKIRA, YAMAGATA, SHOICHI
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetohexamide - therapeutic use Blood Glucose - analysis Cholesterol - blood clofibrate Clofibrate - administration & dosage Clofibrate - pharmacology Diabetes Mellitus - blood Diabetes Mellitus - drug therapy Diabetes Mellitus - enzymology Fatty Acids, Nonesterified - blood Female Humans Lipoprotein Lipase - blood Male Middle Aged Phospholipids - blood plasma triglyceride post-heparin lipolytic activity Triglycerides - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!